Abstract 1744: SAMHD1 expression and impact on clinical outcome in diffuse large B-cell lymphoma: a potential therapeutic target

2019 ◽  
Author(s):  
Waaqo Daddacha
Keyword(s):  
Clinical Outcome ◽  
B Cell ◽  
Therapeutic Target ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Potential Therapeutic Target ◽  
Large B Cell Lymphoma ◽  
Samhd1 Expression ◽  
Large B Cell

scholarly journals Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP

2010 ◽  
Vol 89 (8) ◽  
pp. 783-787 ◽  
Author(s):  
Panagiotis Samaras ◽  
Helen Heider ◽  
Sarah R. Haile ◽  
Ulf Petrausch ◽  
Niklaus G. Schaefer ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Large B Cell Lymphoma ◽  
Large B Cell ◽  
Statin Use

Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP

2009 ◽  
Vol 135 (10) ◽  
pp. 1421-1428 ◽  
Author(s):  
Takeshi Hara ◽  
Hisashi Tsurumi ◽  
Naoe Goto ◽  
Nobuhiro Kanemura ◽  
Takeshi Yoshikawa ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Soluble Fas ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma

2019 ◽  
Vol 18 (9) ◽  
pp. 1520-1532 ◽  
Author(s):  
Taylor Hashiguchi ◽  
Nur Bruss ◽  
Scott Best ◽  
Vi Lam ◽  
Olga Danilova ◽  
...  
Keyword(s):  
B Cell ◽  
Therapeutic Target ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Cyclin Dependent Kinase ◽  
Large B Cell Lymphoma ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document